Related Experiment Video
Updated: May 3, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Synthetic DWI: contrast improvement for diffusion-weighted imaging in prostate using T1 shine-through by synthesizing
Yu Ueda1, Tsutomu Tamada2, Atsushi Higaki2
1Philips Japan, Azabudai Hills Mori JP Tower 15F, 1-3-1 Azabudai, Minato-ku, Tokyo, 106-0041, Japan. yu.ueda@philips.com.
Objective:
To investigate whether synthetic DWI (SyDWI) calculated with short TR and zero TE can improve diffusion contrast in prostate compared to conventional DWI acquired with standard TR and TE.
Materials And Methods:
Thirty-two patients who underwent multiparametric MRI (mp-MRI) on a 3.0 T scanner were enrolled. For SyDWI, DWIs at b0 were acquired with two different TRs and TEs in addition to b1000 and b2000 images acquired with single conventional TR and TE. Contrast ratio (CR) was compared between SyDWI calculated with TR of 1000 ms and TE of 0 ms and conventional DWI acquired with TR of 6000 ms and TE of 70 ms.
Results:
The mean CR between prostate cancer (PCa) and normal prostate, and between PCa and benign prostatic hyperplasia (BPH), is significantly higher in SyDWI compared to conventional DWI for both b-values of 1000 and 2000 s/mm2. In addition, contrast within some lesions is now visualized, suggesting that tumour heterogeneity can be observed that is not seen with conventional DWI.
Conclusion:
SyDWI calculated with TR of 1000 ms and TE of 0 ms significantly improves diffusion contrast between PCa and normal prostate or BPH, and within the lesion, compared to conventional DWI as a result of T1 shine-through.
More Related Videos
15:48Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
09:59A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
